OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neutralization escape of emerging subvariants XBB.1.5/1.9.1 and XBB.2.3 from current therapeutic monoclonal antibodies
De Hoe Chye, Charmaine W. Y. Chew, He Ping Yeo, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 9
Closed Access | Times Cited: 7
De Hoe Chye, Charmaine W. Y. Chew, He Ping Yeo, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 9
Closed Access | Times Cited: 7
Showing 7 citing articles:
SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies
Hailong Guo, Sha Ha, Jason Botten, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 697-697
Open Access | Times Cited: 5
Hailong Guo, Sha Ha, Jason Botten, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 697-697
Open Access | Times Cited: 5
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine
Kayvon Modjarrad, Ye Che, Wei Chen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Kayvon Modjarrad, Ye Che, Wei Chen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Preclinical Characterization of the Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine
Kayvon Modjarrad, Ye Che, Wei Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 14
Kayvon Modjarrad, Ye Che, Wei Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 14
SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development
Fabrizio Angius, Silvia Puxeddu, S Zaimi, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 17-17
Open Access | Times Cited: 3
Fabrizio Angius, Silvia Puxeddu, S Zaimi, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 17-17
Open Access | Times Cited: 3
Development and Evaluation of Vaccination Strategies for Addressing the Continuous Evolution SARS-CoV-2 Based on Recombinant Trimeric Protein Technology: Potential for Cross-neutralizing Activity and Broad Coronavirus Response
Peng Du, Ning Li, Shengjun Tang, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34492-e34492
Open Access | Times Cited: 1
Peng Du, Ning Li, Shengjun Tang, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e34492-e34492
Open Access | Times Cited: 1
Humoral immune response characteristics of the susceptible populations after the infection of SARS-CoV-2 BA.5 strain
Huan Zhang, Shi Ouyang, Zhuolin Li, et al.
Research Square (Research Square) (2024)
Open Access
Huan Zhang, Shi Ouyang, Zhuolin Li, et al.
Research Square (Research Square) (2024)
Open Access
Long-Term SARS-CoV-2-Specific Humoral and T Cell Responses after the BNT162b2 or BBIBP-CorV Booster and the Incidence of Breakthrough Infections among Healthcare Workers
Zsolt Matula, Gabriella Bekő, Viktória Király, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 3-3
Open Access
Zsolt Matula, Gabriella Bekő, Viktória Király, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 3-3
Open Access
